PQS and c-diGMP and its conjugates as adjuvants and their uses in pharmaceutical compositions
申请人:GBF Gesellschaft für Biotechnologische Forschung
mbH
公开号:EP1782826A1
公开(公告)日:2007-05-09
The present invention relates to new adjuvants and the uses in pharmaceutical compositions, like in vaccines. In particular, the present invention provides new compounds useful as adjuvants and/or immunomodulators for prophylactic and/or therapeutic vaccination in the treatment of infectious diseases, inflammatory diseases, autoimmune diseases, tumours, allergies as well as for the control of fertility in human or animal populations. The compounds are particularly useful not only as systemic, but preferably as mucosal adjuvants. In addition, the invention relates to its uses as active ingredients in pharmaceutical compositions.
本发明涉及新型佐剂及其在药物组合物(如疫苗)中的用途。特别是,本发明提供了可用作佐剂和/或免疫调节剂的新化合物,用于预防性和/或治疗性疫苗接种,以治疗传染性疾病、炎症性疾病、自身免疫性疾病、肿瘤、过敏以及控制人类或动物群体的生育能力。这些化合物不仅可作为全身性佐剂,而且最好还可作为粘膜佐剂。此外,本发明还涉及其在药物组合物中作为活性成分的用途。